Literature DB >> 28569359

Early Effects of Sleeve Gastrectomy on Obesity-Related Cytokines and Bile Acid Metabolism in Morbidly Obese Japanese Patients.

Hideharu Shimizu1, Fumihiko Hatao2, Kazuhiro Imamura2, Kijuro Takanishi2, Motoyoshi Tsujino3.   

Abstract

BACKGROUND: Laparoscopic sleeve gastrectomy (LSG) has wide-ranging positive effects on adipocytokine metabolism, bile acid profile, and chronic low-grade inflammation related to obesity. However, the early temporal changes in these markers following LSG have not been well investigated. This study aimed to evaluate the early effects of LSG on adipocytokines, bile acid profile, and inflammatory markers.
METHODS: This was a nonrandomized prospective study examining morbidly obese Japanese patients undergoing LSG. Serial measurements of leptin, adiponectin, bile acids, fibroblast growth factor (FGF)-19, and inflammatory markers were performed preoperatively and 1 and 6 months after LSG.
RESULTS: The study included ten patients (five females) with a mean age of 48.8 years and BMI 40.9 kg/m2. At baseline, 90% of the patients had T2DM, 70% had dyslipidemia, and 90% had hypertension. Patients lost 5.1 kg/m2 BMI at 1 month and 10.1 kg/m2 BMI at 6 months. The leptin levels sharply decreased, and FGF-19 increased significantly as early as 1 month postoperatively. Adiponectin levels showed an increasing trend at 1 month and a significant increase at 6 months. A significant decrease in high-sensitivity CRP and plasminogen activator inhibitor-1 was observed at 6 months. No significant changes were observed in interleukin (IL)-6, IL-8, tumor necrosis factor-α, serum amyloid A protein, or monocyte chemotactic protein-1 throughout the study.
CONCLUSIONS: LSG improved the secretion of adipocytokines, increased FGF-19 secretion soon after surgery, and slowly ameliorated inflammation related to obesity through significant weight loss.

Entities:  

Keywords:  Adipocytokine; Bile acids; Inflammation; Sleeve gastrectomy

Mesh:

Substances:

Year:  2017        PMID: 28569359     DOI: 10.1007/s11695-017-2756-9

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  46 in total

1.  Early effects of gastric bypass on endothelial function, inflammation, and cardiovascular risk in obese patients.

Authors:  Stacy A Brethauer; Helen M Heneghan; Shai Eldar; Patrick Gatmaitan; Hazel Huang; Sangeeta Kashyap; Heather L Gornik; John P Kirwan; Philip R Schauer
Journal:  Surg Endosc       Date:  2011-03-17       Impact factor: 4.584

2.  Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year.

Authors:  Patrizia Ziccardi; Francesco Nappo; Giovanni Giugliano; Katherine Esposito; Raffaele Marfella; Michele Cioffi; Francesco D'Andrea; Anna Maria Molinari; Dario Giugliano
Journal:  Circulation       Date:  2002-02-19       Impact factor: 29.690

3.  Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys.

Authors:  K Hotta; T Funahashi; N L Bodkin; H K Ortmeyer; Y Arita; B C Hansen; Y Matsuzawa
Journal:  Diabetes       Date:  2001-05       Impact factor: 9.461

4.  Adiponectin and bariatric surgery: associations with diabetes and cardiovascular disease in the Swedish Obese Subjects Study.

Authors:  Christian Herder; Markku Peltonen; Per-Arne Svensson; Maren Carstensen; Peter Jacobson; Michael Roden; Lars Sjöström; Lena Carlsson
Journal:  Diabetes Care       Date:  2014-02-26       Impact factor: 19.112

5.  Opposite regulation of interleukin-8 and tumor necrosis factor-alpha by weight loss.

Authors:  Jens M Bruun; Steen B Pedersen; Kurt Kristensen; Bjørn Richelsen
Journal:  Obes Res       Date:  2002-06

6.  FGF19 as a postprandial, insulin-independent activator of hepatic protein and glycogen synthesis.

Authors:  Serkan Kir; Sara A Beddow; Varman T Samuel; Paul Miller; Stephen F Previs; Kelly Suino-Powell; H Eric Xu; Gerald I Shulman; Steven A Kliewer; David J Mangelsdorf
Journal:  Science       Date:  2011-03-25       Impact factor: 47.728

7.  A role for fibroblast growth factor 19 and bile acids in diabetes remission after Roux-en-Y gastric bypass.

Authors:  Glenn S Gerhard; Amanda M Styer; G Craig Wood; Stephen L Roesch; Anthony T Petrick; Jon Gabrielsen; William E Strodel; Christopher D Still; George Argyropoulos
Journal:  Diabetes Care       Date:  2013-07       Impact factor: 19.112

Review 8.  Leptin, resistin and visfatin: the missing link between endocrine metabolic disorders and immunity.

Authors:  Ebtesam A Al-Suhaimi; Adeeb Shehzad
Journal:  Eur J Med Res       Date:  2013-05-01       Impact factor: 2.175

Review 9.  Adipose tissue immune response: novel triggers and consequences for chronic inflammatory conditions.

Authors:  Giorgio Ghigliotti; Chiara Barisione; Silvano Garibaldi; Patrizia Fabbi; Claudio Brunelli; Paolo Spallarossa; Paola Altieri; Gianmarco Rosa; Giovanni Spinella; Domenico Palombo; Razvan Arsenescu; Violeta Arsenescu
Journal:  Inflammation       Date:  2014-08       Impact factor: 4.092

10.  Effects of Roux-en-Y gastric bypass on fasting and postprandial inflammation-related parameters in obese subjects with normal glucose tolerance and in obese subjects with type 2 diabetes.

Authors:  Kirsten Katrine Lindegaard; Nils Bruun Jorgensen; Rasmus Just; Peter Mh Heegaard; Sten Madsbad
Journal:  Diabetol Metab Syndr       Date:  2015-02-24       Impact factor: 3.320

View more
  10 in total

Review 1.  The immune remodel: Weight loss-mediated inflammatory changes to obesity.

Authors:  Charles L Phillips; Bernadette E Grayson
Journal:  Exp Biol Med (Maywood)       Date:  2020-01-19

2.  Gastric Sleeve Surgery Alleviates Obesity-Associated Insulin Resistance and Suppresses Endoplasmic Reticulum Stress in Adipose Tissue of db/db Mice.

Authors:  Ming Sun; Wenyan Zhao; Shuqiang Li; Chunfei Li; Yong Feng; Donghua Geng
Journal:  Obes Surg       Date:  2019-10       Impact factor: 4.129

Review 3.  Effect of Bariatric Surgery on Serum Inflammatory Factors of Obese Patients: a Systematic Review and Meta-Analysis.

Authors:  Moein Askarpour; Dana Khani; Ali Sheikhi; Ehsan Ghaedi; Shahab Alizadeh
Journal:  Obes Surg       Date:  2019-08       Impact factor: 4.129

4.  Acute Changes of Bile Acids and FGF19 After Sleeve Gastrectomy and Roux-en-Y Gastric Bypass.

Authors:  Yutao Chen; Jun Lu; Reza Nemati; Lindsay D Plank; Rinki Murphy
Journal:  Obes Surg       Date:  2019-11       Impact factor: 4.129

Review 5.  Bile acids at the cross-roads of gut microbiome-host cardiometabolic interactions.

Authors:  Paul M Ryan; Catherine Stanton; Noel M Caplice
Journal:  Diabetol Metab Syndr       Date:  2017-12-28       Impact factor: 3.320

6.  Chemerin, Inflammatory, and Nitrooxidative Stress Marker Changes Six Months after Sleeve Gastrectomy.

Authors:  Adriana Florinela Cӑtoi; Alina Elena Pârvu; Aurel Mironiuc; Ştefan Chiorescu; Alexandra Crӑciun; Ioana Delia Pop; Cornel Cӑtoi
Journal:  Oxid Med Cell Longev       Date:  2018-04-11       Impact factor: 6.543

7.  Reduction of IL-6 gene expression in human adipose tissue after sleeve gastrectomy surgery.

Authors:  Isabel Casimiro; Erin C Hanlon; Jeremy White; Avelino De Leon; Ruby Ross; Katiannah Moise; Matthew Piron; Matthew J Brady
Journal:  Obes Sci Pract       Date:  2020-01-15

8.  Ultra-Early and Early Changes in Bile Acids and Insulin After Sleeve Gastrectomy Among Obese Patients.

Authors:  Adriana Florinela Cӑtoi; Alina Elena Pârvu; Aurel Mironiuc; Horațiu Silaghi; Ioana Delia Pop; Andra Diana Andreicuț
Journal:  Medicina (Kaunas)       Date:  2019-11-22       Impact factor: 2.430

9.  Changes in fasting bile acid profiles after Roux-en-Y gastric bypass and sleeve gastrectomy.

Authors:  Chunlan Zhang; Jingjing Zhang; Zhiguang Zhou
Journal:  Medicine (Baltimore)       Date:  2021-01-22       Impact factor: 1.889

Review 10.  Impact of Bariatric Surgery on Adipose Tissue Biology.

Authors:  Óscar Osorio-Conles; Josep Vidal; Ana de Hollanda
Journal:  J Clin Med       Date:  2021-11-25       Impact factor: 4.241

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.